Healthcare Equipment and Supplies
Company Overview of AssureRx Health, Inc.
AssureRx Health, Inc., a personalized medicine company, specializes in pharmacogenomics and helps physicians determine the right medication for individual patients suffering from neuropsychiatric and other disorders. The company offers GeneSight Psychotropic, a test, which analyzes genes that may affect a patient’s response to antidepressant and antipsychotic medications; and GeneSight MTHFR, a genetic test that helps clinicians determine whether additional folic acid supplementation is necessary. It also provides GeneSight ADHD, a test, which analyzes genes that affects a patient’s response to ADHD medications, including stimulant and non-stimulant medications; and GeneSight Analgesic, a te...
6030 South Mason-Montgomery Road
Mason, OH 45040
Founded in 2006
Key Executives for AssureRx Health, Inc.
Chief Executive Officer and President
Chief Financial Officer and Senior Vice President
Chief Operating Officer and Executive Vice President
Chief Science Officer and Senior Vice President
Compensation as of Fiscal Year 2014.
AssureRx Health, Inc. Key Developments
U.S. Department of Veterans Affairs Approves Assurex Health's GeneSight(R) for Clinical Use in VA Health System
Jun 24 14
Assurex Health announced that the U.S. Department of Veterans Affairs (VA) has approved its Federal Supply Schedule (FSS) contract as a government supplier, effective June 15, 2014, making the GeneSight(R) Psychotropic test available for use in VA facilities nationwide. GeneSight Psychotropic, developed by the company, analyzes how an individual's genetic makeup affects response to a broad panel of medications prescribed for mental health conditions including depression, post-traumatic stress disorder, anxiety, bipolar disorder, and schizophrenia.
Assurex Health Announces Management Changes
Jun 17 14
Assurex Health named James S. Burns Executive Chairman and Virginia (Gina) C. Drosos as President and Chief Executive Officer, effective July 1, 2014. Burns, who has served as CEO since 2009, will chair the Board of Directors, as well as focusing on long-term development of Assurex Health's proprietary technology platform and overseeing the company's Scientific Advisory Board. Drosos, who joined the company in August 2013, adds the CEO role to her responsibilities as President and leader of the commercial organization and fast growing program to drive broad awareness and adoption of GeneSight.
Assurex Health Secures $32 Million in Financing to Support Continued Growth
May 21 14
Assurex Health announced that it has secured a $25 million Term and Revolving Credit Facility to support increasing clinical adoption of its GeneSight(R) products. GE Capital, Healthcare Financial Services, acting as Agent, and Silicon Valley Bank financed the credit facility. Existing investors, including funds managed by Sequoia Capital, Claremont Creek Ventures, Mayo Clinic, Cincinnati Children's Hospital Medical Center, CincyTech, Allos Ventures, Four Rivers Partners, Danmar Capital, and jVen Capital, provided an additional $7 million to complete the $32 million financing. The new financing will help Assurex Health continue building the leading neuropsychiatric personalized medicine company.
Similar Private Companies By Industry
Recent Private Companies Transactions
May 21, 2014